Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CONFIRM-HF – Targeting for Improvement in Exercise Capacity in Heart Failure
Author(s): Piotr Ponikowski Added: 9 years ago

Heart Failure
Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
Author(s): Sunil K Nadar , Muhammad Mujtaba Shaikh Added: 3 years ago
Dear Editor, We would like to thank García-Escobar and Ingelmo for their letter regarding our article on the use of biomarkers in routine clinical care for heart failure.1,2 It was with interest that we read their comments on the use of red cell volume distribution width (RDW) as another biomarker for use in the management of patients with heart failure. As mentioned in their letter, RDW is a… View more

Heart Failure
Author(s): Cristiana Vitale , Ilaria Spoletini , Giuseppe Rosano Added: 3 years ago
Exercise intolerance is a typical symptom of heart failure (HF), impairing patients’ ability to perform activities of daily living and affecting quality of life (QOL).1 Chronic HF is characterised by a progressive reduction in exercise capacity, increasing fatigue and shortness of breath.2 In addition, exercise intolerance is often accompanied by increased blood pressure and chronotropic… View more

Heart Failure
e-SPACE Heart Failure 2023
Author(s): Stefan Anker , Giuseppe Rosano , Javier de Juan Bagudá , et al Added: 5 months ago
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023. A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring… View more

Heart Failure

Prevention & Chronic Conditions
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers
Author(s): John GF Cleland Added: 10 months ago
ESC-HFA 23 - Prof John Cleland (University of Glasgow, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562). IRONMAN was a randomised, open-label multicenter trial, which aimed to assess the effectiveness of intravenous iron in patients with heart failure and iron deficiency as compared to standard care. It demonstrated that the administration of IV FDI was associated with lower rates… View more

Heart Failure